Company name: Sublime Culture
Also known as: Sublime
Description: Producer of medical cannabis intended for medical purposes regulations. The company’s products include raw ingredients and consumer products derived from cannabis crops grown without pesticides, herbicides, or insecticides, enabling food, beverage and pharmaceutical industries to get a range of quality bio-active products.
Year founded: 2013
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: CannaTechnology sold a 23% stake in the company to MYM Nutraceuticals (CNQ: MYM) for an undisclosed amount on May 4, 2018. The acquisition will enable the acquirer to expand its shareholding in the company to 74% and thus improve its cannabis production capabilities.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 0.39
Last known valuation date: 22-Feb-2017